YHLO News

Language

YHLO News

Marketing Activities

Home page

Global registration overview of YHLO diagnostic kits for Novel Coronavirus COVID-19 Antigen/Antibody

Time Posted ：2024-04-03

View Details

Peking University—YHLO Joint Lab Achieved Another Great Result

Time Posted ：2024-03-04

On June 24th, Peking University—YHLO Joint Laboratory for Molecular Diagnostics of Infectious Diseases published in Journal of Infection（2021 IF: 38.637） an article entitled “Antibody efficacy of inactivated vaccine boosters (CoronaVac) against Omicron variant from a 15-month follow-up study”, which revealed the immune response and protection against the Omicron variant before and after three doses of the inactivated COVID-19 vaccine.

View Details

YHLO COVID-19 Rapid Test Effectively Detect More Mutant Strains

Time Posted ：2024-03-04

Recently, the BA.5 and BA.4 variants of the Omicron subtype have spread rapidly in many countries and areas worldwide. The experts have analysed that due to the mutation of the SARS-CoV-2 spike protein again, the BA.4 and BA.5 variants are able to evade human immunity, which can lead to infection or reinfection of "almost everyone", including people who have been vaccinated or who have been cured from SARS-CoV-2.

View Details

YHLO Medical Device Industrial Park in Hunan Start Construction

Time Posted ：2024-03-04

On July 25, 2022, the YHLO Medical Device Industrial Park was announced to start construction in Hunan Province. The total area of construction is up to 200,000 square meters. It is estimated to be completed and put into production in July 2025. The park will be one of the research and development centres of the YHLO iModules Integration System for Immunoassay and the subsidiary brand Drawray microfluidics products. The new park will be the basic facility for YHLO’s further development.

View Details

YHLO innovative iFlash series showcased at the 2022 AACC Expo

Time Posted ：2024-03-04

From July 26-28, YHLO was showcased at the American Association of Clinical Chemistry 2022 Clinical Lab Expo. The YHLO exhibit booth featured the Chemiluminescence Immunoassay solutions that can provide labs with better efficiency and reliability. And the highly-automated Mono-test Analyzer iStar 500, the Immunofluorescence Reader Unicell and the Vision ESR Analyzer are also showcased to attendees.

View Details

YHLO Newest IVDR Certificate Extended to 72 Products

Time Posted ：2024-03-04

In August 2022, YHLO received the newest IVDR Certificate from BSI, one of the most reputable notified bodies for medical device CE certifications. The IVDR certificate of YHLO covers additional 58 YHLO chemiluminescent immunoassay (CLIA) detection products including TSH, Cardiolipin IgG, AMH, CA 15-3, CK-MB, HSV-1 IgG etc. Until today, YHLO has obtained IVDR CE Certificate of 72 products, covering the autoimmunity, reproductive health, tumor markers, cardiac markers, infection detection fields and so forth.

View Details